Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of industrial park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothing. The company also offers property and value-added services. Shanghai Haixin Group Co., Ltd. was founded in 1986 and is headquartered in Shanghai, China.
Frequently asked questions
What sector does Shanghai Haixin Group Co Ltd A (600851) operate in?
Shanghai Haixin Group Co Ltd A belongs to the Healthcare sector and operates in the Conglomerates industry.
What is Shanghai Haixin Group Co Ltd A (600851) current stock price?
As of the latest data, Shanghai Haixin Group Co Ltd A stock price is CN¥8.33, with a previous close of CN¥8.27. Shanghai Haixin Group Co Ltd A gained CN¥0.06 in the last trading session, representing a 0.73% increase.
What is Shanghai Haixin Group Co Ltd A (600851) current market capitalization?
Shanghai Haixin Group Co Ltd A market cap is approximately 6.15 billion.
What is Shanghai Haixin Group Co Ltd A (600851) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.16.
What is Shanghai Haixin Group Co Ltd A (600851) Price-to-Earnings (P/E) ratio?
Shanghai Haixin Group Co Ltd A current P/E ratio is 52.06.
Does Shanghai Haixin Group Co Ltd A (600851) pay dividends?
No. Shanghai Haixin Group Co Ltd A does not pay a dividend.
What is Shanghai Haixin Group Co Ltd A (600851) beta (volatility) score?
Shanghai Haixin Group Co Ltd A has a beta of 0.600, indicating lower volatility than the overall market.
